The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
Feichtenschlager V, Chen L, Zheng YJ, Ho W, Sanlorenzo M, Vujic I, Fewings E, Lee A, Chen C, Callanan C, Lin K, Qu T, Hohlova D, Vujic M, Hwang Y, Lai K, Chen S, Nguyen T, Muñoz DP, Kohwi Y, Posch C, Daud A, Rappersberger K, Kohwi-Shigematsu T, Coppé JP, Ortiz-Urda S.
Feichtenschlager V, et al. Among authors: chen l, chen c, chen s.
Mol Cancer. 2024 Feb 22;23(1):40. doi: 10.1186/s12943-024-01955-7.
Mol Cancer. 2024.
PMID: 38383439
Free PMC article.